Canadian Pharmacovigilance and Risk Management Conference

Overview

DIA’s Canadian Pharmacovigilance and Risk Management Conference is the premier place to hear from expert pharmaceutical, biotechnology, and regulatory personnel. The latest updates in pharmacovigilance, risk management, and drug safety will be presented from both a global and a tailored Canadian perspective.

Need approval in order to attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

Travel Once, Learn Twice

Receive $150 off your registration fee when you register for this meeting and the co-located DIA Annual Canadian Meeting.

Who should attend?

Professionals involved in:

Clinical Safety/Pharmacovigilance

Clinical Research and Clinical Operations

Quality Assurance and Control

Regulatory Affairs and Operations

Policy

Compliance and Legal Affairs

Learning objectives

At the end of this session participants should be able to:

Describe recent regulatory agency initiatives in Canada, Europe, and the US, to strengthen pharmacovigilance and risk management efforts within their respective regions
Discuss recent updates to the Canada Vigilance database and perspectives of Health Canada and industry on opportunities and challenges that these changes pose
Compare and contrast pharmacovigilance inspections by Health Canada, MHRA, and FDA, and discuss recent findings from Health Canada inspections
Discuss Health Canada and industry perspectives on current pharmacovigilance risk management requirements and best practices in Canada

Program Committee

Rita Cassola, RPh • Executive Director PV
Certus PV Services Inc, Canada
Marcia Bailey, BSN, MHS, RN • Senior Manager, Pharmacovigilance
Sierra Oncology , Canada
Colin D'Cunha, MD, MHS, FRCPC • Director, Global Medical Affairs
Apotex Inc., Canada
Mélanie Derry, PhD • Associate Director
Health Canada, Canada
Marc F. Poitras, PhD, MBA • Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
Health Canada, Canada